ATOMWISE
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Dec 2025)
What this means for you
This application is over — abandoned 22 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90731554
- Mark type
- Stylized text
- Filed
- 24 May 2021
- Published for opposition
- 20 Sept 2022
- Abandoned
- 22 Dec 2025
- Attorney of record
- Carla B. Oakley
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals, namely, anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceuticals for the treatment of rare diseases, vascular diseases and conditions, neurologic diseases and conditions, rheumatology conditions and diseases, and psychiatric conditions and diseases; chemical preparations and biological preparations for the treatment of diseases and disorders; herbicides, insecticides and pesticides
Owner
- Atomwise Inc., San Francisco, CA, US
- Atomwise Inc., San Francisco, CA, US
Prior registrations
Prosecution history
- 22 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2025 — SOU EXTENSION 5 GRANTED
- 01 May 2025 — SOU EXTENSION 5 FILED
- 01 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Nov 2024 — SOU EXTENSION 4 GRANTED
- 07 Nov 2024 — SOU EXTENSION 4 FILED
- 26 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 07 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2024 — SOU EXTENSION 3 GRANTED
- 06 May 2024 — SOU EXTENSION 3 FILED
- 06 May 2024 — SOU TEAS EXTENSION RECEIVED